Travere Therapeutics President and CEO Eric Dube Plans to Step Down

04:42 PM EDT, 09/21/2026 (MT Newswires) -- Travere Therapeutics (TVTX) said late Monday its president and chief executive officer Eric Dube has decided to step down to focus on his health and family. The board has unanimously selected Bradley Campbell, former president and CEO of Amicus Therapeutics, to succeed Dube as president, CEO and board member, starting Dec. 1, the company said. Travere Therapeutics said Dube will continue to serve as president and CEO until Dec. 1 and will remain employed by the company as an executive advisor through Feb. 15, 2027, to support the leadership transition.